5-hydroxydecanoate has been researched along with sb 216763 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berdeaux, A; Chenoune, M; Couvreur, N; Ghaleh, B; Pons, S; Tissier, R; Waintraub, X | 1 |
1 other study(ies) available for 5-hydroxydecanoate and sb 216763
Article | Year |
---|---|
The ceiling effect of pharmacological postconditioning with the phytoestrogen genistein is reversed by the GSK3beta inhibitor SB 216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione] through mitochondrial ATP-dependent potassium c
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Decanoic Acids; Estradiol; Genistein; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart; Heart Rate; Hydroxy Acids; Indoles; Ischemic Preconditioning, Myocardial; KATP Channels; Male; Maleimides; Mitochondria; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Phosphorylation; Proto-Oncogene Proteins c-akt; Rabbits | 2009 |